Japan Ventures Progress Cell And Gene Candidates For ALS, Severe Conditions

BioJapan Showcases Recent Progress

BioJapan 2024 was joined by numerous ventures with novel modalities in the country (Lisa Takagi)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Scrip

More from Focus On Asia